Title : A phase II study of S-1 in relapsed small cell lung cancer.

Pub. Date : 2013 Mar

PMID : 24649158






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 S-1 is a new oral fluoropyrimidine derivative designed to enhance anticancer activity and reduce gastrointestinal toxicity. 2-fluoropyrimidine proteasome 26S subunit, non-ATPase 1 Homo sapiens